BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22746009)

  • 21. Neck dissection for surgical treatment of lymphnode metastasis in papillary thyroid carcinoma.
    Ducci M; Appetecchia M; Marzetti M
    J Exp Clin Cancer Res; 1997 Sep; 16(3):333-5. PubMed ID: 9387910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pro and contra lymphadenectomy in papillary and follicular thyroid gland carcinoma].
    Seiler CA; Schäfer M; Büchler MW
    Zentralbl Chir; 2000; 125(10):835-40; discussion 840-1. PubMed ID: 11098579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current diagnostic method, prognosis estimation and therapy of papillary thyroid cancer: recommendations of the medical universities and the National Oncologic Institute of Budapest].
    Esik O; Balázs C; Boér A; Csernay L; Földes J; Füzy M; Horváth OP; Julesz J; Kásler M; Laczi F; Leövey A; Lukács G; Németh G; Perner F; Repa I; Szabolcs I; Szentirmay Z; Trón L; Balázs G
    Orv Hetil; 2000 Jan; 141(1):5-16. PubMed ID: 10673852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
    Mathonnet M
    Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node dissection in papillary or follicular thyroid carcinoma.
    Bononi M; Tocchi A; Cangemi V; Vecchione A; Giovagnoli MR; De Cesare A; Fiori E; Volpino P; Brozzetti S; Meucci M; Scozzafava S; Cavallaro A
    Anticancer Res; 2004; 24(4):2439-42. PubMed ID: 15330196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term course in differentiated thyroid gland carcinoma].
    Rösler H; Birrer A; Lüscher D; Kinser J
    Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of "locally advanced" well-differentiated thyroid carcinomas.
    Falvo L; Catania A; Grilli P; Di Matteo FM; De Antoni E
    Ann Ital Chir; 2004; 75(1):17-21. PubMed ID: 15283382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
    Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
    Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma.
    Bhattacharyya N
    Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1101-4. PubMed ID: 14568796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low-risk papillary thyroid cancer. What is the procedure of choice for thyroidectomy and lymph node resection?].
    Cougard P; Peix JL; Kraimps JL
    Ann Chir; 2005; 130(6-7):411-3. PubMed ID: 15907781
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study.
    Son YI; Jeong HS; Baek CH; Chung MK; Ryu J; Chung JH; So YK; Jang JY; Choi J
    Ann Surg Oncol; 2008 Jul; 15(7):2020-6. PubMed ID: 18459004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
    Włoch J; Czarniecka A; Turska M; Wilgus J
    Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiated thyroid cancer: role of the lymph node dissection.
    Caglià P; Zappulla E; Costa S; Tracia M; Veroux M; Russo V; Borzì L; Lucifora B; Patanè G; Tracia L; Amodeo C
    G Chir; 2010; 31(6-7):293-5. PubMed ID: 20646374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.
    Zetoune T; Keutgen X; Buitrago D; Aldailami H; Shao H; Mazumdar M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2010 Dec; 17(12):3287-93. PubMed ID: 20596784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of papillary microcarcinoma of the thyroid gland.
    Orsenigo E; Beretta E; Fiacco E; Scaltrini F; Veronesi P; Invernizzi L; Gini P; Fiorina P; Di Carlo V
    Eur J Surg Oncol; 2004 Dec; 30(10):1104-6. PubMed ID: 15522558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.